February 3, 2022

Name of listed company: Chugai Pharmaceutical Co., Ltd.

Code number:

4519 (1st Section of Tokyo Stock Exchange)

Head office:

1-1,Nihonbashi-Muromachi2-Chome,Chuo-ku, Tokyo

President & CEO:

Osamu Okuda

Inquiries to:

Toshiya Sasai

Head of Corporate Communications Dept.

Tel: +81-(0)3-3273-0554

F. Hoffmann-La Roche Announces Financial Results for fiscal 2021

F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today its financial results for fiscal 2021 (January 1 - December 31, 2021).

Roche owns 59.89% of Chugai's outstanding shares (61.16% of the total number of shares issued excluding treasury stock) as of the end of December 2021.

Its press release and presentation materials can be found on its website (https://www.roche.com).

Chugai's performance for the period of January 1 to December 31, 2021 is included in the announced Roche Group's results.

Investor Updates

Presentations / Annual Report

###

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Chugai Pharmaceutical Co. Ltd. published this content on 03 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 February 2022 06:08:12 UTC.